Hims & Hers Faces Securities Suit After FTC Data-Sharing Complaint
San Francisco – September 10, 2026 -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain executives now face a securities class action after a July 29, 2026 federal complaint from the Federal Trade Commission wiped over $970 million from the company's market capitalization in a single trading session, sending shares down $4.32, or 14.7%.
FTC alleges Hims shared health data with Meta and Snap despite privacy pledges
The FTC complaint, filed alongside co-plaintiffs the State of Utah and Los Angeles County representing California, accuses Hims of surreptitiously sharing sensitive user medical conditions and personal health data with third-party advertising platforms including Meta Platforms and Snap. Regulators allege the company used embedded tracking pixels and customer list matching to transmit this data, contradicting public assurances that it maintained administrative, physical, and technical safeguards for health and personal information.